Probmet Therapeutics logo

Probmet Therapeutics

An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients.

2 employees · est. 2022 · Denmark

VS
Shorla Oncology logo

Shorla Oncology

At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers.

38 employees · est. 2018 · Ireland

Shorla Oncology is the older company (2022 vs 2018); Shorla Oncology is the larger of the two.

Side-by-Side Comparison

Probmet Therapeutics Shorla Oncology
Founded
2022 2018 older
Headquarters
Denmark Ireland
Employees
2 38 larger
Industry
Health Care, Health and Wellness Health Care, Manufacturing, Pharmaceutical
Funding Stage
Convertible Note Series B
Total Funding
$500.00K $43.30M
Funding Rounds
1 2
Services
Targeted Cancer Treatments, Drug Discovery and Development, Clinical Trial Research, Biomarker Strategy Not tracked yet
Target Customers
Breast Cancer Patients with Brain Metastasis, Oncologists and Clinical Researchers, Pharmaceutical and Biotech Companies Not tracked yet
Taxonomy
Oncology Therapeutics, Targeted Treatments, Breast Cancer, Brain Metastasis, Precision Medicine, Metastatic Cancer, Therapeutic Development, Innovation In Cancer Treatment, Breakthrough Therapies, Neuroscience Oncology, Cancer Research, Pharmaceuticals Oncology Drugs, Cancer Treatments, Women's Health, Pediatric Oncology, Drug Development, Commercialization, Unmet Medical Needs, Clinical Impact, Innovation, Life-saving Treatments
Website
probmet.com shorlaoncology.com
Probmet Therapeutics logo

About Probmet Therapeutics

Probmet Therapeutics, headquartered in Denmark, is making strides in the field of precision oncology with a focus on developing new therapies for metastatic breast cancer in the brain. Founded in 2022, the company operates within the Health Care and Health and Wellness industries. Its core mission r...

Shorla Oncology logo

About Shorla Oncology

Shorla Oncology is an Irish healthcare startup that focuses on the development and commercialization of innovative oncology drugs, particularly targeting women's and pediatric cancers. Founded in 2018, the company's mission is to address the gaps in existing cancer treatments by providing accessible...

We will tell you when either one moves

BounceWatch watches Probmet Therapeutics and Shorla Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Probmet Therapeutics and Shorla Oncology — by email.

Frequently Asked Questions

Probmet Therapeutics — An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients. . Shorla Oncology — At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Probmet Therapeutics has raised $500.00K while Shorla Oncology has raised $43.30M.
Probmet Therapeutics and Shorla Oncology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Probmet Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Probmet Therapeutics on 14 Mar 2026, and Shorla Oncology on 25 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy